News

Bupropion Hydrochloride extended-release tablets (SR), available in 150mg strength, are the generic equivalent of Wellbutrin SR and are indicated for the treatment of major depressive disorder. Bupropion Hydrochloride

The SISR trial is a multi-center, randomized study of 384 patients from 26 academic and community health centers in the US. This longer-term, follow-up analysis focused on pre-specified

These new findings are consistent with overall results from the Horizons-AMI trial that demonstrate treatment with Angiomax resulted in superior net clinical outcomes and fewer cardiac deaths when

In this trial, 15 patients have now been enrolled and, to date, 60% (nine patients) have had slower than expected disease progression. NOV-002 was well-tolerated, further extending the

The new assay can be run in a fully automated, random access format on the Vitros ECi/ECiQ Immunodiagnostic System, with results readily available in less than 50 minutes.

As previously announced, Eisai has filed the infringement actions in December 2005 contesting Teva’s submission of an abbreviated new drug application (ANDA) to the FDA for Aricept (donepezil

Bethanechol chloride is indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. Arthur Bedrosian,

The Phase I study will initially evaluate escalating single-agent doses of SGN-35 administered weekly to patients with relapsed or refractory CD30-positive hematologic malignancies, including Hodgkin lymphoma. Following the

In the study four insulin dependent patients have received DiabeCell implants with no remarkable adverse events. Two of the patients have completed six months observation and maintained significant